Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review

Nefeli Giannopoulou, Constantina Constantinou

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: Colorectal cancer was reported as the second most common cause of cancer death worldwide, in the year 2020. This disease is an important public health problem considering its high incidence and mortality rates. Summary: The molecular events that lead to colorectal cancer include genetic and epigenetic abnormalities. Some of the most important molecular mechanisms involved include the APC/β-catenin pathway, the microsatellite pathway, and the CpG island hypermethylation. Evidence in the literature supports a role for the microbiota in the development of colon carcinogenesis, and specific microbes may contribute to or prevent carcinogenesis. Progress in prevention, screening, and management has improved the overall prognosis of the disease when diagnosed at an early stage; yet metastatic disease continues to have a poor long-term prognosis due to late-stage diagnosis and treatment failure. Biomarkers are a key tool for early detection and prognosis and aim to reduce morbidity and mortality associated with colorectal cancer. The main focus of this narrative review is to provide an update on the recent development of diagnostic and prognostic biomarkers in stool, blood, and tumor tissue samples. Key Messages: The review focuses on recent investigations in microRNAs, cadherins, Piwi-interacting RNAs, circulating cell-free DNA, and microbiome biomarkers which can be applied for the diagnosis and prognosis of colorectal cancer.

Original languageEnglish
Pages (from-to)675-684
Number of pages10
JournalOncology (Switzerland)
Volume101
Issue number10
DOIs
Publication statusPublished - 1 Oct 2023
Externally publishedYes

Keywords

  • Colorectal cancer
  • Diagnostic markers
  • MicroRNAs
  • Pathophysiology
  • Prognostic markers

Fingerprint

Dive into the research topics of 'Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review'. Together they form a unique fingerprint.

Cite this